Royal Bank Of Canada Prelude Therapeutics Inc Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 3,344 shares of PRLD stock, worth $3,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,344

Previous 3,721 10.13%

Holding current value

$3,076

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.64 - $1.39 $241 - $524	-377 Reduced 10.13%	3,344 $2,000
Q4 2024 Feb 14, 2025	BUY	$0.8 - $2.04 $692 - $1,766	866 Added 30.33%	3,721 $4,000
Q3 2024 Nov 14, 2024	SELL	$2.07 - $6.37 $173 - $535	-84 Reduced 2.86%	2,855 $5,000
Q2 2024 Aug 14, 2024	BUY	$3.32 - $5.63 $2,941 - $4,988	886 Added 43.16%	2,939 $11,000
Q1 2024 Nov 05, 2024	SELL	$2.68 - $4.84 $2,374 - $4,288	-886 Reduced 30.15%	2,053 $9,000
Q1 2024 May 15, 2024	SELL	$2.68 - $4.84 $18,725 - $33,817	-6,987 Reduced 77.29%	2,053 $9,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $4.37 $6,721 - $17,379	3,977 Added 78.55%	9,040 $38,000
Q3 2023 Nov 14, 2023	SELL	$2.74 - $4.79 $591 - $1,034	-216 Reduced 4.09%	5,063 $15,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $8.12 $93 - $170	21 Added 0.4%	5,279 $23,000
Q1 2023 May 15, 2023	BUY	$4.58 - $7.34 $4,392 - $7,039	959 Added 22.31%	5,258 $29,000
Q4 2022 Feb 14, 2023	BUY	$4.61 - $8.5 $456 - $841	99 Added 2.36%	4,299 $25,000
Q3 2022 Nov 14, 2022	BUY	$5.0 - $8.82 $8,495 - $14,985	1,699 Added 67.93%	4,200 $28,000
Q2 2022 Aug 15, 2022	SELL	$4.0 - $7.55 $2,660 - $5,020	-665 Reduced 21.0%	2,501 $13,000
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $11,495 - $22,024	-1,666 Reduced 34.48%	3,166 $22,000
Q4 2021 Feb 14, 2022	SELL	$11.89 - $31.74 $879 - $2,348	-74 Reduced 1.51%	4,832 $61,000
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $32,225 - $48,312	1,250 Added 34.19%	4,906 $153,000
Q2 2021 Aug 16, 2021	BUY	$28.63 - $44.3 $104,671 - $161,960	3,656 New	3,656 $104,000

Others Institutions Holding PRLD

# of Institutions

Shares Held

28.3M

Call Options Held

23.9K

Put Options Held

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $33.5M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Prelude Therapeutics Inc Transaction History